IP Library › Granted Patent US 12,220,476
Granted Patent B2
US 12,220,476 · App. 17/806,294 · Granted Feb 11, 2025

Composition for controlled release of actives

Inventors: Wilson A. Lee (Hauppauge, NY); Robert Maidhof (Kings Park, NY); Danielle Erin Maslin (Setauket, NY)
Assignee: ELC Management LLC
A61K8/8147A61K8/345A61K8/365A61K8/368A61K8/735A61Q19/00A61K2800/95
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,220,476
App. No.
17/806,294
Granted
Feb 11, 2025
Kind
B2
Abstract

Topical film forming compositions that are able to efficiently deliver active ingredients to keratinic surfaces in a timed release manner comprise a combination of acrylates copolymer and acrylates/VA copolymer, and a combination of propane-1,3 diol and glycerin. The sizes of the pores that develop in the dried film may be controlled or fine tuned.

Claims (17)

1. A topical aqueous composition for controlled release of active ingredients comprising:

a film former that comprises acrylates/vinyl acetate copolymer and acrylates copolymer in a weight ratio of 10:1 to 30:1, wherein the weight of the acrylates/vinyl acetate copolymer and acrylates copolymer combined comprise 20%-60% of the weight of the total composition;

a porosity adjuster that comprises propane-1,3 diol and glycerin in a weight ratio of 1:1 to 4:1, wherein the weight of the propane-1,3 diol and glycerin combined comprise 5.5% to 10% by total weight of the composition; and

one or more cosmetically acceptable active ingredients at a total concentration of 0.0001% to 10%, by weight of the composition.

2. The topical aqueous composition according to claim 1 wherein the active ingredient is salicylic acid.

3. The topical aqueous composition according to claim 1 wherein the active ingredient is hyaluronic acid.

4. The topical aqueous composition according to claim 1 wherein the active ingredient is glycolic acid.

5. The topical aqueous composition according to claim 1 wherein the weight ratio of acrylates/vinyl acetate copolymer to acrylates copolymer ranges from 15:1 to 25:1.

6. The topical aqueous composition according to claim 1 wherein the weight ratio of propane-1,3 diol to glycerin ranges from 1:1 to 3:1.

7. The topical aqueous composition according to claim 1 wherein the propane-1,3 diol and glycerin combined comprise 5.5% to 7% by total weight of the composition.

8. A method of making a delivery system for controlled release of active ingredients, the method comprising the steps of:

a) providing a topical aqueous composition according to claim 1 ;

b) applying the composition to a substrate; and

c) allowing the composition to dry to a film, such that pores develop in the film,

wherein the active ingredients accumulate in the pores that develop in the film.

9. The method according to claim 8 wherein the average size of the pores ranges from about 1.5 μm to about 3.0 μm.

10. The method according to claim 8 wherein the average size of the pores ranges from about 0.1 μm to about 1.5 μm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2023
From: LEE, WILSON A., DR.; MAIDHOF, ROBERT; MASLIN, DANIELLE ERIN
To: ELC MANAGEMENT LLC
Reel/Frame 064317/0807 →
Continuity (1)
Related Publication 20230398054A1 · Dec 14, 2023
References Cited (65)
US 2949403A · Andreadis et al. · 1960 [cited by applicant]
US 4708865A · Turner · 1987 [cited by applicant]
US 4803195A · Holzner · 1989 [cited by applicant]
US 5374614A · Behan et al. · 1994 [cited by applicant]
US 5874072A · Alwattari et al. · 1999 [cited by applicant]
US 6171605B1 · Bevacqua et al. · 2001 [cited by applicant]
US 6403109B1 · Stora · 2002 [cited by applicant]
US 6774101B2 · Stora et al. · 2004 [cited by applicant]
US 7223382B2 · Sokolinsky et al. · 2007 [cited by applicant]
US 7226901B2 · Stora · 2007 [cited by applicant]
US 7323162B2 · Martin et al. · 2008 [cited by applicant]
US 7655613B2 · Vlad et al. · 2010 [cited by applicant]
US 7682621B2 · Lamberty et al. · 2010 [cited by applicant]
US 7794694B2 · Giacomoni et al. · 2010 [cited by applicant]
US 7846889B2 · Vlad et al. · 2010 [cited by applicant]
US 8343521B2 · Shick et al. · 2013 [cited by applicant]
US 8920787B2 · Li et al. · 2014 [cited by applicant]
US 8932570B2 · Mu et al. · 2015 [cited by applicant]
US 9072686B2 · Bui et al. · 2015 [cited by applicant]
US 9078835B2 · Bui et al. · 2015 [cited by applicant]
US 9301910B2 · Yontz · 2016 [cited by applicant]
US 9535897B2 · Anderson et al. · 2017 [cited by applicant]
US 10373079B2 · Lamere et al. · 2019 [cited by applicant]
US 10515400B2 · Krishnamurthy et al. · 2019 [cited by applicant]
US 10699321B2 · Krishnamurthy et al. · 2020 [cited by applicant]
US 10813874B2 · Lee et al. · 2020 [cited by applicant]
US 11103439B2 · Lee · 2021 [cited by applicant]
US 11129788B1 · Lee · 2021 [cited by examiner]
US 11291618B2 · Mohammadi · 2022 [cited by examiner]
US 20030082129A1 · Buckingham et al. · 2003 [cited by applicant]
US 20030186836A1 · Dumanois et al. · 2003 [cited by applicant]
US 20040161435A1 · Gupta · 2004 [cited by applicant]
US 20040209795A1 · Vlad · 2004 [cited by applicant]
US 20050053567A1 · Liu · 2005 [cited by applicant]
US 20060257342A1 · Mu et al. · 2006 [cited by applicant]
US 20080286217A1 · Chaudhuri · 2008 [cited by applicant]
US 20110073126A1 · Mu et al. · 2011 [cited by applicant]
US 20120160258A1 · Cruz et al. · 2012 [cited by applicant]
US 20150004115A1 · Tan et al. · 2015 [cited by applicant]
US 20160283564A1 · Sharon et al. · 2016 [cited by applicant]
US 20170189296A1 · SaNogueira et al. · 2017 [cited by applicant]
US 20180075137A1 · Lifar et al. · 2018 [cited by applicant]
US 20180369119A1 · Lee · 2018 [cited by applicant]
US 20190000382A1 · Fitzpatrick · 2019 [cited by applicant]
US 20190179915A1 · Yoon et al. · 2019 [cited by applicant]
US 20200155430A1 · Lee et al. · 2020 [cited by applicant]
US 20200320112A1 · Bansal et al. · 2020 [cited by applicant]
US 20210169769A1 · Lee · 2021 [cited by applicant]
US 20210299031A1 · Lee · 2021 [cited by examiner]
FR 2954155B1 · 2012 [cited by applicant]
FR 2954152B1 · 2012 [cited by applicant]
JP 2013121949A · 2013 [cited by applicant]
JP 2014208636 · 2014 [cited by applicant]
KR 1020090114884 · 2009 [cited by applicant]
KR 1020160016980A · 2016 [cited by applicant]
KR 1020190036341A · 2019 [cited by applicant]
WO WO9913861 · 1999 [cited by examiner]
WO WO2019074668A1 · 2019 [cited by examiner]
Aculyn 33; Rheology Modifier/Stabilizer A Cost-Effective Thickener for Formulations Containing Polar Solvents; Technical Data Sheet, 2002. [cited by applicant]
Mintel; GNPD; False Lashes; Record ID: 1961135; Parfums Christian Dior; Parfums Christian Dior; Dior Grand Bal; Colour Cosmetics; Eye Colour Cosmetics—Eye Lash; Japan; Dec. 2012. [cited by applicant]
Mintel; GNPD; Mascara S302; Record ID: 1513924; Tokiwa Pharmaceutical Co.; Tokiwa Pharmaceutical Co.; Sana Gafixx; Colour Cosmetics; Eye Colour Cosmetics—Eye Lash; Japan; Mar. 2011. [cited by applicant]
Mintel; GNPD; Record ID: 3127979; Mascara; Pola, Pola, Pola Muselle Nocturnal; Colour Cosmetics; Eye Colour Cosmetics—Eye Lash; Japan; Apr. 2015. [cited by applicant]
Mintel; GNPD; Smudgeproof Mascara; Record ID: 3344417; Albion; Technolabo; Paul & Joe Summer 2015; Colour Cosmetics; Eye Colour Cosmetics—Eye Lash; Japan; Jul. 2015. [cited by applicant]
PCT International Search Report; International Application No. PCT/US2023/068157; Completion Date: Sep. 25, 2023; Mailing Date: Sep. 25, 2023. [cited by applicant]
PCT Written Opinion of the International Searching Authority: International Application No. PCT/US2023/068157; Completion Date: Sep. 25, 2023. [cited by applicant]